Status: current, Primitive. Date: 30-Sep 2021. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4636049012 | Teneligliptin hydrobromide (substance) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
| 4636050012 | Teneligliptin hydrobromide | en | Synonym | Active | Case insensitive | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Teneligliptin hydrobromide | Is a | Enzyme inhibitor | false | Inferred relationship | Some | ||
| Teneligliptin hydrobromide | Is a | Dipeptidyl peptidase IV inhibitor | true | Inferred relationship | Some | ||
| Teneligliptin hydrobromide | Is a | Carboxylic acid and/or carboxylic acid derivative | true | Inferred relationship | Some | ||
| Teneligliptin hydrobromide | Has disposition | Dipeptidyl peptidase IV inhibitor | true | Inferred relationship | Some | ||
| Teneligliptin hydrobromide | Is modification of | Teneligliptin | true | Inferred relationship | Some | ||
| Teneligliptin hydrobromide | Is a | Drug or medicament | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Teneligliptin (as teneligliptin hydrobromide) 20 mg oral tablet | Has precise active ingredient | True | Teneligliptin hydrobromide | Inferred relationship | Some | 1 |
Reference Sets
Substance foundation reference set
Australian dialect reference set
FHIR